Abnormal activity of voltage-gated sodium channels (VGSCs) is related to several pathological processes, including cardiac arrhythmias, epilepsy, cancer, neurodegenerative diseases, spasticity, chronic and neuropathic pain. As such VGSCs are considered important therapeutic targets.
Sodium channel blockers: a patent review (2010 - 2014) / Zuliani, Valentina; Rapalli, Alberto; Patel, Manoj K; Rivara, Mirko. - In: EXPERT OPINION ON THERAPEUTIC PATENTS. - ISSN 1354-3776. - 25:3(2015), pp. 279-290. [10.1517/13543776.2014.995628]
Sodium channel blockers: a patent review (2010 - 2014)
ZULIANI, Valentina;RIVARA, Mirko
2015-01-01
Abstract
Abnormal activity of voltage-gated sodium channels (VGSCs) is related to several pathological processes, including cardiac arrhythmias, epilepsy, cancer, neurodegenerative diseases, spasticity, chronic and neuropathic pain. As such VGSCs are considered important therapeutic targets.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
